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ﻦﻜﻟﻭ٬ﺔﻌﺋﺎﺷﺮﻴﻏﻲﻠﺠﻨﻤﻟﺍﻡﺪﻟﺍﺮﻘﻓﻰﺿﺮﻣﻯﺪﻟﻦﻴﻌﻟﺍﺝﺎﺠﺣﺕﺎﻔﻋﺎﻀﻣﺮﺒﺘﻌﺗ
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.ﺓﺭﺩﺎﻨﻟﺍﺕﺎﻔﻋﺎﻀﻤﻟﺍﻩﺬﻫﺩﻮﺟﻭﻊﻣﻲﻠﺠﻨﻤﻟﺍﻡﺪﻟﺍﺮﻘﻓﻰﺿﺮﻣﺕﻻﺎﺤﻟﻲﺣﺍﺮﺠﻟﺍ
ﻲﻠﺠﻨﻤﻟﺍﻡﺪﻟﺍﺮﻘﻓ؛ﺀﺎﺸﺘﺣﺍ؛ﻦﻴﻌﻟﺍ؛ﻂﻐﺿ:ﺔﻴﺣﺎﺘﻔﻤﻟﺍﺕﺎﻤﻠﻜﻟﺍ
tcartsbA
-mocnu era esaesid llec elkcis ni snoitacilpmoc latibrO
tnacfiingis ni tluser ot hguone ereves eb nac tub ,nom
llec elkcis htiw yob dlo-raey-01 a troper eW .ytidibrom
,amede dileye laretalib ,revef htiw detneserp ohw esaesid
eye tfel htiw noisiv dehsinimid dna ,sisotporp* Corresponding address: Department of Infection Prevention
and Control, King Fahad Central Hospital, P O Box 402, Jazan
45142, KSA.
E-mail: arishih@hotmail.com (H.M. Arishi)
Peer review under responsibility of Taibah University.
Production and hosting by Elsevier
1658-3612  2015 Taibah University.
Production and hosting by Elsevier Ltd. This is an open access article u
licenses/by-nc-nd/3.0/). http://dx.doi.org/10.1016/j.jtumed.2014.08.002involvement more than the right eye. Investigations
revealed anemia, thrombocytopenia, and derangement of
coagulation profile consistent with disseminated intra-
vascular coagulopathy, and salmonella species was
recovered from blood culture. MRI of the orbits showed
bilateral large subperiosteal hematomas. The treatment
included intravenous antibiotics, pulse methylpredniso-
lone and bilateral canthotomy with surgical drainage of
the hematomas. Postoperative visual assessment revealed
complete loss of vision in the left eye with normal vision
in right eye. This case highlights the importance of the
early evaluation and consideration of surgical interven-
tion in sickle cell disease with this rare complication.
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Sickle cell disease (SCD) is an autosomal recessive dis-
order characterized by production of abnormal hemoglobin
S and is associated with high morbidity and mortality.
Studies have reported that SCD is a relatively common ge-
netic disorder in this part of the world. The prevalence of
SCD in Kingdom of Saudi Arabia varies significantly in
different parts of the country, with the highest prevalence is
in the eastern and the southwestern provinces respectively.1
Ocular manifestations of sickle cell disease may include
anterior segment ischemia, secondary glaucoma, angoid
streaks, retinopathy and retinal artery occlusions.2 Auto-
infarction of the orbital bones has rarely been reported andnder the CC BY-NC-ND license (http://creativecommons.org/
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and potentially, compressive optic neuropathy, constituting
orbital compression syndrome (OCS).Case report
A 10-year-old Saudi boy known to have sickle beta-
thalassemia referred from a peripheral hospital on 12th
January 2013 after hospitalization there due to fever and left
upper and lower limb pain for three days. Six hours prior
admission to our hospital, he developed bilateral eyelids
edema, proptosis and diminished vision in the left more than
the right eye. He was managed in the referring hospital with
intravenous fluids, antibiotics, analgesia and blood trans-
fusions. There was no history of trauma or insect bite. He
had history of repeated admissions due to vaso-occlusive
crisis. He is on regular folic acid and prophylactic oral
penicillin.
On examination, he looked sick, drowsy, pale and mildly
icteric. His temperature was 38.7 C; heart rate 120 ⁄min;
respiratory rate 22 ⁄min; blood pressure 105/66 mm Hg and
O2 saturation (room air) was 98%. His weight was 22 kg;
height, 126 cm; head circumference 53 cm and all were within
normal centiles. He had bilateral extensive periorbital edema
and proptosis in left eye more than the right. There was
bilateral conjunctival chemosis, subconjunctival hemorrhage
and corneal haziness. Ocular motility was restricted in all
directions and Pupils were not reacting to light bilaterally.
Abdomen was soft with mildly enlarged liver and spleen.
There was tenderness and restriction of the range of motion
of the left shoulder and left hip joints with no other focal
signs of inflammation.Figure 1: A, axial T1 weighted. B, coronal T1 weighted image show w
iso-intense and includes hyper intense areas. Masses are seen to arise fr
3  2 cm while on right is 2  1.6 cm. On left, mass pushes and distoLaboratory results showed a hemoglobin of 8.8 g/dL;
mean cell volume 60.8 fl; white cell count 6.8  109/L, with
neutrophils 66.9%; platelets 24 109/L. Serum bilirubin was
104 mmol/L, albumin was 25 g/L, ALT 108 U/L, AST 433 U/
L. Blood urea was 3.5 mmol/L, and serum creatinine was
43 mmol/L. Coagulation parameters revealed a prothrombin
time (PT) of 18 s (normal 10e13); International Normali-
zation Ratio INR) 1.45 (normal 0.85e1.12) and activated
partial prothrombin time (aPTT) 55 s (normal 26.4e36). D-
Dimer was elevated 7.97 mg/mL. Serum fibrinogen level was
not available. Erythrocyte sedimentation rate was 134 mm/h
(normal <11 mm/h), and C-reactive protein was 12.8 mg/dL
(normal <0.5 mg/dL). Hemoglobin electrophoresis showed
HbS 58%, HbA 36%, HbF 2%, and HbA2 4% (consistent
with sickle bþ thalassemia). Urine examination was normal
and culture reported negative. Salmonella species was grown
from blood culture. The organism was sensitive to third
generation cephalosporins and ciprofloxacin. Magnetic
resonance imaging (MRI) of the orbit showed bilateral
orbital masses with heterogenous intensity suggestive of he-
matomas. The lesion size was 2 3 cm on left and 2 1.6 cm
on right side (Figure 1A,B). Sagital and coronal, fat
suppression T2-weighed images showed similar lesions
arising from roof and lateral wall of each orbit. The eye
globes were displaced anteriorly with more affection on left
side. The optic nerve on left side small and is displaced with
partial loss of its surrounding cerebrospinal fluid
(Figure 2A,B). However, evidence of bone infarction could
not be demonstrated.
He was managed in pediatric intensive care unit with
hydration, analgesia, intravenous (IV) vancomycin and
cefotaxime and IV pulse methylprednisolone. Ophthal-
mology service was consulted and to save potential vision inell defined mass lesions with heterogenous signal intensity, mostly
om roof and lateral walls of each orbit. On left side mass measures
rts eye globe, compressing and displacing left optic nerve.
Figure 2: A, sagital T2 weighted fat suppression. B, coronal T2 weighted fat suppression. They show lobulated masses of heterogenous
signal intensity in both orbits. On left the larger mass (2  3 cm)is noted to push eye globe anteriorly, compressing and displacing the optic
nerve which appears small with partial loss of its surrounding cerebrospinal fluid.
Compression syndrome in sickle cell disease498right eye, decision for urgent drainage of subperiosteal he-
matomas was made. The patient was operated on the same
day of admission after he received supportive management
for coagulation derangement. Surgical approach was under
upper orbital rim, about 10 ml of blood was drained from
each orbit and drains were kept in place. Postoperatively he
was kept on IV antibiotics and topical eye medications as
well as regular assessment by ophthalmology and pediatric
teams. After the result of blood culture, vancomycin was
discontinued. The left eye had drained about 180 ml of blood
in the first day, volume of drainage then reduced to minimal
oozing over the next 5 days. He continued to receive blood
and blood products and one dose of recombinant factor Vlla.
He showed gradual improvement with reduction in swelling
and ocular movement with mild restriction of upward gaze of
left eye. Three weeks postoperatively, his visual acuity was
20⁄20 in the right and minimal perception of light in left eye.
Fundoscopic examination was normal in right eye and
documented optic atrophy in left eye. On fifth day of
admission a swelling and tenderness were noted on proximal
part of left humerus close to shoulder joint. Ultrasono-
graphic examination of left shoulder revealed soft tissue
swelling around the joint and small non-drainable collection
at the subacromial region. X-ray of left shoulder including
upper half of humerus were normal. This x-ray was repeated
two weeks later and revealed cortical irregularity, periosteal
new bone information of proximal one-third of left humerus
and normal epiphysis. These findings were consistent with
osteomyelitis of this bone. Antibiotics were continued for six
weeks.Discussion
Sickle cell disease (SCD) is an inherited hemoglobinopa-
thy which results from a point mutation (GAG/ GTG) in
exon 1 of the b globin gene resulting in the substitution of
glutamic acid by valine at position 6 of the b globin poly-
peptide chain.3 An abnormal hemoglobin S molecule is
formed, and tends to polymerize under conditions of
hypoxia and acidosis. This will cause the red blood cell to
become sickle in shape and rigid. These cells have short life
span (chronic hemolysis) and tend to block capillaries
(vaso-oclusion) which explain almost all clinical
manifestations of sickle cell disease.4 Ophthalmologic
complications can result from vaso-occlusion in any
vascular bed in the eye, including the conjunctiva, anterior
segment, retina, choroid, or optic nerve with potentially
vision-threatening consequences,2 however, orbital
involvement is a rare finding.5 Orbital compression
syndrome (OCS) is an acute condition characterized by
eyelid edema, proptosis, periorbital pain, restriction of
extra-ocular motility, with or without decreased visual acu-
ity.6,7 Themainmechanism for development ofOCS is orbital
bone infarction with subsequent inflammatory response that
can rapidly spread to the orbit resulting in orbital pain and
proptosis and other features of OSC.8 A unique feature of
orbital wall infarction in sickle cell disease is the formation
of hematomas, which may be orbital (subperiosteal) or
intracranial (epidural).8e10 Several mechanisms have been
suggested for development of subperiosteal hemorrhage,
such as extravasation of blood from necrosed vessel walls,
M.A. Yateem et al. 499underlying bleeding diathesis, and minor trauma.8,10 The
presumed cause of orbital hematoma in our case is
coagulopathy as a complication of salmonella septicemia in
the setting of orbital infarction, but such infarction was not
apparent on MRI of the orbital bones. In the initial reports,
OCS has been thought to result from the occlusion of the
ophthalmic vessels at the apex of the orbit by sickled cells.11
To best of our knowledge, 36 cases of OCS have been
reported.7,12e17 Most of the cases, 83% (30/36), occur in
homozygous hemoglobin S. However, OCS has been
reported in other sickle cell disease variants, five cases in
sickle b-thalassemia, and one case in hemoglobin SC
disease.7,17 Orbital wall infarction typically occurs in youths
because there is more marrow space in the orbital bone in
children than there is in adults.8 The mean age of
presentation in 36 reported cases was 13 years, with the
youngest reported age at 2 years.15 It affects almost twice as
many male as females. The OCS has wide spectrum of
manifestations ranging from its mild form which constitutes
of pain and eyelid edema, the presentations that occur in all
cases, to the most severe of bilateral proptosis, chemosis,
limited ocular motility, and vision loss, like the presentation
in our case.6 Fever at presentation occur in almost all cases,
and associated pain crises elsewhere was seen in more than
two third of cases.7 Bilateral orbital involvement is reported
in one third of cases.7 The differential diagnosis of acute
periorbital pain and swelling with or without other
manifestations of OCS in patient with sickle cell disease
includes orbital cellulitis, orbital abscess, periorbital
cellulitis, osteomyelitis of orbital bone, orbital tumor, and
orbital bone infarction.6,7,14,18 To differentiate between
bone infarct and the infective process involving the orbit is
crucial and can be challenging in case of orbital
osteomyelitis. The presence of Leukocytosis and elevated
erythrocyte sedimentation rate and C-reactive protein can
occur in both bone infection and infarction.14 Bone marrow
abnormalities are well depicted at MR imaging, and orbital
soft-tissue swelling, subperiosteal hemorrhage, and fluid
collections often are seen in association with such abnor-
malities.10 Bone marrow scan can confirm marrow infarction
in 95% of cases by demonstrating decreased tracer uptake, in
infection the uptake is normal.6 MRI is the imaging modality
of choice for evaluation of OCS in most of the reported cases.
Our case is unique because the condition is associated with
salmonella sepsis and disseminated intravascular
coagulopathy which we think played a role in formation of
the hematomas, and caused osteomyelitis of the left
humerus. MRI shows bilateral large subperiosteal
hematomas compressing the eye globes and optic nerves
with more mass effect on the left side which contributed to
loss of vision. However, infarction of orbital bones was not
evident. Most cases of OCS resolve with conservative
treatment.6,7,19 Administration of intravenous
corticosteroids may relieve orbital pressure caused by
inflammatory component of orbital bone infarction.
Concomitant antibiotic coverage is advisable as it is often
difficult to clinically differentiate osteomyelitis from bone
infarction.6e8 Surgical exploration and evacuation of
hematoma is warranted to prevent vision loss and to speed
recovery if there are signs of optic nerve dysfunction or
large hematomas are demonstrated by MRI.8,19 29 of 36
(80.5%) patients reported in the literature recovered withmedical therapy, and seven (19.4%) required surgical
interventions. Among the reported cases, only one case
ends with permanent visual loss in the patient left eye. This
patient had severe bilateral disease and was managed
conservatively.7 Our patient is the second case in which
OCS is complicated by unilateral blindness. Clinical visual
assessment; significant eye globe displacement, thinning and
touristy of optic nerve on MRI were predictive of this poor
outcome in left eye. The rational for surgical intervention
and draining of hematomas despite laboratory evidence of
DIC is to save whatever vision left in right eye and
minimize morbidity of bilateral visual loss. Three months
after discharge, postoperative and outpatient follow up
assessment confirmed visual acuity of 20/20 in the right eye,
permanent visual loss in the left eye and cure of
osteomyelitis of left humerus.
Conclusion
The diagnosis of OCS should be considered when patients
with SCD present with proptosis, decreased extra ocular
motility, eyelid edema, and optic neuropathy. Children with
SCD are susceptible to infections, and empirical use of broad
spectrum antibiotics should be considered if infectious pro-
cess is suspected. An ophthalmologist should always be
consulted, as early evaluation and surgical intervention if
evidence of optic nerve dysfunction or large hematoma is
present can be vision saving.
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